These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 25401099)

  • 1. A Meta-Analysis on the Relations between EGFR R521K Polymorphism and Risk of Cancer.
    Wang Y; Zha L; Liao D; Li X
    Int J Genomics; 2014; 2014():312102. PubMed ID: 25401099
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Relations between EGFR R521K Polymorphism and Risk of Cancer: Need for Clarification of Data in a Recent Meta-Analysis.
    Jiang J; Li Y; Dai L; Wu H; Hu M
    Int J Genomics; 2015; 2015():597413. PubMed ID: 25874199
    [No Abstract]   [Full Text] [Related]  

  • 3. The EGFR R521K polymorphism influences the risk to develop colorectal cancer.
    Martinelli M; Ugolini G; Scapoli L; Rivetti S; Lauriola M; Mattei G; Rosati G; Montroni I; Manaresi A; Zattoni D; Taffurelli M; Solmi R
    Cancer Biomark; 2010-2011; 8(2):61-5. PubMed ID: 21896992
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of epidermal growth factor receptor polymorphism, skin toxicity, and outcome in patients with squamous cell carcinoma of the head and neck receiving cetuximab-docetaxel treatment.
    Klinghammer K; Knödler M; Schmittel A; Budach V; Keilholz U; Tinhofer I
    Clin Cancer Res; 2010 Jan; 16(1):304-10. PubMed ID: 20028750
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analysis of the polymorphisms EGFR-r521K and ERBB2-I655V in Mexican patients with gastric cancer and premalignant gastric lesions.
    Torres-Jasso JH; Bustos-Carpinteyro AR; Marín ME; Santiago E; Leoner C; Flores-Luna L; Torres J; Sánchez-Lopez JY
    Rev Invest Clin; 2013; 65(2):150-5. PubMed ID: 23844533
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epidermal growth factor receptor expression in gastric tumors and its relationship with the germline polymorphisms - 216 G>T, -191 C>A, (CA) n IVS1, and R521K.
    Torres-Jasso JH; Bustos-Carpinteyro AR; Garcia-Gonzalez JR; Peregrina-Sandoval J; Cruz-Ramos JA; Santiago-Luna E; Sanchez-Lopez JY
    Indian J Cancer; 2016; 53(3):345-348. PubMed ID: 28244453
    [TBL] [Abstract][Full Text] [Related]  

  • 7. EGF and EGFR genetic polymorphisms predict prognosis in locally advanced pharyngolaryngeal squamous cell carcinoma patients receiving postoperative concurrent chemoradiotherapy.
    Su NW; Leu YS; Lee JC; Liu CJ; Cheng CY; Lin JS; Chen YJ; Chen CK; Fang IC; Hsieh RK; Chang YF
    Onco Targets Ther; 2014; 7():2197-204. PubMed ID: 25506224
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association between EGFR gene polymorphisms, skin rash and response to anti-EGFR therapy in metastatic colorectal cancer patients.
    Jaka A; Gutiérrez-Rivera A; Ormaechea N; Blanco J; La Casta A; Sarasqueta C; Izeta A; Tuneu A
    Exp Dermatol; 2014 Oct; 23(10):751-3. PubMed ID: 25039761
    [TBL] [Abstract][Full Text] [Related]  

  • 9. EGFR R521K predicts cetuximab response in KRAS wild-type patients.
    Marsh S
    Pharmacogenomics; 2012 May; 13(7):746. PubMed ID: 22754965
    [No Abstract]   [Full Text] [Related]  

  • 10. Association of epidermal growth factor receptor (EGFR) gene polymorphism with lung cancer risk: a systematic review.
    Feng X; Qin JJ; Zheng BS; Huang LL; Xie XY; Zhou HF
    J Recept Signal Transduct Res; 2014 Oct; 34(5):333-4. PubMed ID: 24495289
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Polymorphisms of EGFR predict clinical outcome in advanced non-small-cell lung cancer patients treated with Gefitinib.
    Ma F; Sun T; Shi Y; Yu D; Tan W; Yang M; Wu C; Chu D; Sun Y; Xu B; Lin D
    Lung Cancer; 2009 Oct; 66(1):114-9. PubMed ID: 19201048
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The polymorphism (Gln261Arg) of 12-lipoxygenase and cancer risk: a meta-analysis.
    Shan D; Shen K; Zhu J; Feng M; Wu Y; Wan C; Shen Y; Xu L
    Int J Clin Exp Med; 2015; 8(1):488-95. PubMed ID: 25785021
    [TBL] [Abstract][Full Text] [Related]  

  • 13. EGFR intron 1 dinucleotide repeat polymorphism is associated with the occurrence of skin rash with gefitinib treatment.
    Huang CL; Yang CH; Yeh KH; Hu FC; Chen KY; Shih JY; Lin ZZ; Yu CJ; Cheng AL; Yang PC
    Lung Cancer; 2009 Jun; 64(3):346-51. PubMed ID: 18995924
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relationship between Aurora-A V57I Polymorphism and the Risk of Cancer: A Meta-Analysis and Trial Sequential Analysis.
    Chen G; Hu C; Song Y; Xiu M; Zhang Y; Lai P; Li Y; Liu X; Huang P
    J Cancer; 2020; 11(11):3225-3234. PubMed ID: 32231728
    [No Abstract]   [Full Text] [Related]  

  • 15. Lack of association between the BIM deletion polymorphism and the risk of lung cancer with and without EGFR mutations.
    Ebi H; Oze I; Nakagawa T; Ito H; Hosono S; Matsuda F; Takahashi M; Takeuchi S; Sakao Y; Hida T; Faber AC; Tanaka H; Yatabe Y; Mitsudomi T; Yano S; Matsuo K
    J Thorac Oncol; 2015 Jan; 10(1):59-66. PubMed ID: 25384174
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The relationship between BIM deletion polymorphism and clinical significance of epidermal growth factor receptor-mutated non-small cell lung cancer patients with epidermal growth factor receptor-tyrosine kinase inhibitor therapy: a meta-analysis.
    Zou Q; Zhan P; Lv T; Song Y
    Transl Lung Cancer Res; 2015 Dec; 4(6):792-6. PubMed ID: 26798589
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The association between miR-146a gene rs2910164 polymorphism and gastric cancer risk: a meta-analysis.
    Fu B; Song P; Lu M; Wang B; Zhao Q
    Biomed Pharmacother; 2014 Oct; 68(8):923-8. PubMed ID: 25455160
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association between
    Moazeni-Roodi A; Hashemi M
    Mol Biol Res Commun; 2018 Sep; 7(3):119-124. PubMed ID: 30426029
    [TBL] [Abstract][Full Text] [Related]  

  • 19. P53 codon 72 polymorphism, human papillomavirus infection, and their interaction to oral carcinoma susceptibility.
    Hou J; Gu Y; Hou W; Wu S; Lou Y; Yang W; Zhu L; Hu Y; Sun M; Xue H
    BMC Genet; 2015 Jun; 16():72. PubMed ID: 26123760
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human 8-oxoguanine DNA glycosylase gene polymorphism (Ser326Cys) and cancer risk: updated meta-analysis.
    Kang SW; Kim SK; Park HJ; Chung JH; Ban JY
    Oncotarget; 2017 Jul; 8(27):44761-44775. PubMed ID: 28415770
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.